newsfilter
← Latest News
GlobeNewswire·

Nkarta to Participate in March Investor Conferences

  • Nkarta, Inc. (NASDAQ: NKTX) announced participation in two investor conferences on March 2 & March 10, 2026.
  • The company will present at the TD Cowen 46th Annual Health Care Conference in Boston, MA, at 9:10 a.m. EST on March 2, 2026.
  • Nkarta will present at the Leerink Global Healthcare Conference in Miami, FL, at 10:40 a.m. EDT on March 10, 2026.
  • A simultaneous webcast for both events will be available on Nkarta's Investor section, with replays archived for approximately 90 days.
  • Nkarta is a clinical-stage biotechnology company developing allogeneic, off-the-shelf NK cell therapies for autoimmune diseases.
  • The company utilizes a cell expansion & cryopreservation platform combined with proprietary cell engineering technologies to build its therapeutic pipeline.